Health

  • June 17, 2026

    Opioid Clinic To Pay $10M To Resolve False Treatment Claims

    A Rhode Island opioid treatment provider and its former CEO have agreed to pay $10.2 million to resolve allegations they billed Medicaid and Medicare for treatments they did not provide, according to the U.S. Department of Justice.

  • June 17, 2026

    Doctors Defeat Most Claims In Life Insurance Fraud Dispute

    A life insurer failed to adequately allege that a pair of doctors were knowingly involved in a purported scheme to defraud the carrier into issuing $160 million worth of policies, a New Jersey federal court ruled, tossing all but one claim brought under the state's Insurance Fraud Protection Act.

  • June 17, 2026

    Lab Owner Avoids 'Very Long' Prison Term For $89M Fraud

    A Utah businessman who cooperated with prosecutors after admitting his role in a false Medicare claims scheme was sentenced Wednesday in New Jersey federal court to three years of probation and ordered to forfeit $28 million.

  • June 17, 2026

    Medical Spa Investment Co. Files Ch. 11 With $10M+ Debt

    An investment management firm specializing in medical spas and medical aesthetics providers has filed for Chapter 11 protection in Delaware with $10 million to $50 million in debt.

  • June 17, 2026

    Mangione To Use 'Mental Defect' Defense In NY Murder Trial

    A New York state judge revealed Wednesday that Luigi Mangione will argue he was suffering a "mental defect" at the time he allegedly murdered UnitedHealthcare CEO Brian Thompson.

  • June 16, 2026

    Feds Say NY Health Officials Aided Fraud In Medicaid Program

    New York health officials rigged the bidding process for managing the state's $10 billion Medicaid homecare program, and the state-chosen steward didn't deliver on its promises, which has harmed patients and caregivers and cost American taxpayers millions of dollars, the U.S. Department of Justice alleged in a lawsuit Tuesday.

  • June 16, 2026

    Wash. Judge Won't Revisit Order On Ed. Dept. School Grants

    A federal judge in Seattle will not reconsider her decision declining to enforce an earlier order barring the U.S. Department of Education from ceasing school mental health grants, saying Washington and other plaintiff states have not shown that the court erred.

  • June 16, 2026

    Ga. Justices Uphold $42M Verdict In Hospital Death Suit

    The Georgia Supreme Court refused to grant a new trial or lower a $42 million jury verdict in a wrongful death case filed by the fiance and estate of a woman who died in the hospital after giving birth to her daughter by cesarean section.

  • June 16, 2026

    Sanofi Sued Over Qunol CoQ10 'Superior Absorption' Claims

    Sanofi-Aventis US deceives customers into believing its Qunol liquid CoQ10 supplements have "superior absorption" advantages compared to regular CoQ10 products despite scientific testing that shows otherwise and prior legal action that barred it from making similar efficacy claims, alleges a proposed class action filed Monday in New Jersey federal court.

  • June 16, 2026

    Eli Lilly Settles Mounjaro TM Suit Against Seattle Area Clinics

    Eli Lilly has agreed to drop a lawsuit accusing two Washington clinics of ripping off its trademarks for the weight loss drugs Mounjaro and Zepbound, according to a voluntary dismissal motion filed in federal court on Monday, almost two weeks after a judge rejected a resolution proposed by the parties. 

  • June 16, 2026

    WestRock Must Face Class Claims Over Wash. Paper Mill Odor

    A group of Washington and Oregon residents can proceed with a proposed class action accusing paper mill operator WestRock Longview LLC of negligently releasing noxious gases that sickened neighbors and hurt property values, a Washington federal judge ruled Monday.

  • June 16, 2026

    J&J Fails To Undo $65.5M Verdict In Minn. Talc Cancer Case

    A Minnesota state judge on Monday upheld a $65.5 million verdict awarded to a mother of three children who had claimed that Johnson & Johnson's talc products exposed her to asbestos and contributed to her cancer, saying that the jury's decision was supported by the evidence at trial.

  • June 16, 2026

    Cigna Loses Privilege Bid Due To 'Inaccurate, Redundant' Log

    Cigna "improperly asserted privilege" over hundreds of documents that three laboratories sought as part of the discovery process in federal payment litigation in Connecticut, according to a special master appointed by the judge in the consolidated cases.

  • June 16, 2026

    Judge Allows Pfizer, Moderna Defenses In GSK Vax IP Dispute

    A Delaware federal judge on Tuesday permitted Pfizer and Moderna to move ahead with their arguments that GlaxoSmithKline patents the company claims are infringed by the COVID-19 vaccines are unenforceable because of an unreasonable delay in obtaining them.

  • June 16, 2026

    Anti-Abortion Group Renews Bid To Block NJ's Info Demand

    An anti‑abortion pregnancy center urged a federal judge to block New Jersey's attorney general from enforcing a subpoena seeking financial donor information, arguing in a renewed bid for a preliminary injunction that the demand is retaliatory and persists despite a U.S. Supreme Court ruling allowing the group to challenge the investigation.

  • June 16, 2026

    J&J Talc Trial In LA Ends With Deadlocked Jury

    A mistrial was declared Monday by a Los Angeles state judge in a two-month trial over allegations Johnson & Johnson's talc products caused a woman's deadly mesothelioma after the jury deadlocked during deliberations, according to counsel for the plaintiff.

  • June 16, 2026

    Md. Judge Continues Health Case Law Streak With ACA Ruling

    U.S. District Judge Brendan Abell Hurson in Baltimore has been on the bench for less than three years. He's already building an impressive list of healthcare rulings.

  • June 16, 2026

    Pfizer Agrees To Deal To End Depo-Provera MDL

    The plaintiffs in the multidistrict litigation accusing Pfizer of failing to warn consumers of a link between brain tumors and the hormonal contraceptive Depo-Provera have reached an agreement with the pharmaceutical giant, according to an order filed Monday.

  • June 16, 2026

    Academic Group Fights Feds' Bid For Lawsuit Funding Info

    The Association of American Universities told a Massachusetts federal court on Monday it should not be required to open its books to prove it's eligible to recover attorney fees for successfully defeating the U.S. Department of Health and Human Services' caps on indirect research costs last year.

  • June 16, 2026

    Remote Workers Tell 6th Circ. Boot-Up Time Compensable

    Remote call center workers handling inbound patient calls from home have argued before a Sixth Circuit panel that their employer failed to pay them in accordance with the Fair Labor Standards Act for pre-shift computer startup work integral to their jobs.

  • June 16, 2026

    FCC Urged To Revise Test Rule Language

    A trade group representing commercial, scientific and testing laboratories in the U.S. has asked the Federal Communications Commission to narrowly tailor the language of a planned rule that would restrict accreditation for labs that test communications equipment.

  • June 15, 2026

    Med Groups Slam HHS 'Red Herring' Bid To Fast-Track Appeal

    Medical groups who won an order halting the Trump administration's modified childhood vaccination schedule on Monday urged the First Circuit to ignore the U.S. Department of Health and Human Services' "red herring" arguments for an expedited appeal, saying the agency has for months stalled the process.

  • June 15, 2026

    Cognizant, Infosys Can't Shield Execs From Depositions

    Infosys Ltd. and Cognizant TriZetto Software Group Inc. will each have to produce executives to speak on certain topics for depositions in a Texas federal lawsuit over claims that Infosys stole Cognizant's trade secrets to build a competing healthcare software, a special master ruled Monday.

  • June 15, 2026

    DOJ Says NY Court Can't Block Texas Trans Records Probe

    The U.S. Department of Justice urged a New York federal court Monday to deny a request for an order barring the government from seeking transgender minor patients' medical records through a criminal subpoena issued by a Texas grand jury, arguing the court lacks jurisdiction.

  • June 15, 2026

    Attys Want Up To $33M In Long-Running UBH Benefits Fight

    Attorneys for employee benefit plan participants who sued to change how United Behavioral Health processed claims for mental health and substance use disorder treatment asked a California federal court for up to $33 million in fees and expenses for their work on the "groundbreaking" case.

Expert Analysis

  • Opinion

    Rule Of Law Requires Gov't Engagement With Bar, Not Retreat

    Author Photo

    A federal agency's absence from national and local bar conferences, most recently illustrated by the U.S. Department of Justice's withdrawal from a New York City Bar Association white collar conference, disserves the bar, the government lawyers themselves and, ultimately, the administration of justice, says Muhammad Faridi at Linklaters.

  • AG Watch: Oregon's Strategic Civil Enforcement Approach

    Author Photo

    Oregon Attorney General Dan Rayfield’s recent antitrust litigation activity and proposed staffing increase are the latest in a series of structural and policy changes that signal that the state Department of Justice is taking a more aggressive approach to civil enforcement, says Keturah Taylor at Cozen O'Connor.

  • Fed. Circ. Clarifies Standard For Contesting CICA Overrides

    Author Photo

    The Federal Circuit's recent holding in Life Science Logistics strengthens the hand of protesters facing an override of the Competition in Contracting Act stay, and a Court of Federal Claims decision the same day demonstrates that how a protester frames its requested relief remains critically important, says Richard Arnholt at Bass Berry.

  • The Paradoxical Duty To Adopt AI When You Can't Bill For It

    Author Photo

    Both billing for hours saved using artificial intelligence and preserving billable time by not adopting AI may violate rules of professional conduct, but until bar associations' ethics rules catch up to this emerging economic dilemma, firms must decide how to adjust fee structures themselves, says Ines Lassalle at Peyrot & Associates.

  • A Decade Later, Escobar Is Still Shaping FCA Cases

    Author Photo

    The U.S. Supreme Court's decision 10 years ago in Universal Health Services v. U.S. ex rel. Escobar changed the way in which lower courts evaluate False Claims Act cases — and the ruling remains vital in nearly every FCA case filed today, say attorneys at Bradley Arant.

  • How Hantavirus May Expand Cruise Ship Liability Concerns

    Author Photo

    In an incident like the recent hantavirus outbreak aboard a cruise ship, application of maritime negligence principles may expand beyond environmental exposure considerations to encompass how operators identify, respond to and manage emerging infectious disease risks in real time, says Eric Shane at Leesfield & Partners.

  • Ch. 15 Ruling Is A Restructuring Blueprint For Cannabis Cos.

    Author Photo

    The recent Cannabist Chapter 15 recognition order is arguably the most significant cannabis bankruptcy development in U.S. history, providing a concrete and tested road map by which such companies with foreign parent structures can access the protective machinery of U.S. bankruptcy law, say attorneys at Saul Ewing.

  • How FCA, FCPA Risks Are Shifting As Feds Pull Back

    Author Photo

    As the federal government continues its retreat from white collar enforcement, companies should expect False Claims Act risk to grow through private whistleblower suits and Foreign Corrupt Practices Act scrutiny to shift toward foreign prosecutors, requiring more adaptability as accountability becomes less centralized, says Temidayo Aganga-Williams at Selendy Gay.

  • Trump Admin's Agency Records Purge Tests Judicial Notice

    Author Photo

    While courts commonly take judicial notice of data in government websites and reports, the Trump administration's recent modification or wholesale deletion of these sources means that litigants must look elsewhere to support trial admission of this information, says Jon Gryskiewicz at Lewis Baach.

  • Series

    Cow Horse Makes Me A Better Lawyer

    Author Photo

    Moving an unwilling 800-pound cow while riding a horse at high speed is exhilarating, a little unhinged and, at least for me, a surprisingly effective training ground for litigation — both demand focus, preparation over rigid planning and the willingness to act despite fear, says Ashley Zitrin at Glenn Agre.

  • PowerSchool Data Breach Ruling Underscores PE Liability

    Author Photo

    The recent California federal court decision in PowerSchool, where Bain Capital was unable to dismiss claims relating to a data breach based in part on Bain's preinvestment activities, is an important addition to the line of cases addressing investor liability for acts of a portfolio company, says Mark Kelley at MoloLamken.

  • What Prop 65 Listings For Welding Fumes, Drugs Mean For Cos.

    Author Photo

    With California poised to add welding chemicals and three medications to its list of known carcinogens under Proposition 65, businesses must assess risks from nontraditional pharmaceutical dispensing, occupational and environmental exposures to welding operations, and downstream exposures from the manufacture of both types of substances, says Gregory Berlin at Alston & Bird.

  • West Coast Health Cos. Must Brace For Federal Enforcement

    Author Photo

    In light of the U.S. Department of Justice's newly established West Coast strike force targeting healthcare fraud across Northern California, Arizona and Nevada, health organizations will need to prioritize knowledge, vigilance and operational discipline to reduce exposure from potentially parallel criminal and civil investigations, says Michael Beckwith at Dickinson Wright.

  • High Court's Hikma Decision Reshapes 'Skinny Label' Suits

    Author Photo

    The U.S. Supreme Court's decision in Hikma v. Amarin marks a significant victory for generic drug manufacturers, but rather than putting an end to so-called skinny label inducement claims, it narrows and refocuses them, say attorneys at Sterne Kessler.

  • Checking For AI Errors Is Now A Two-Way Street

    Author Photo

    A handful of recent federal and state cases demonstrate the importance of checking for errors generated by artificial intelligence not only in your own court submissions, but also your opponent's, as well as when catching opposing counsel's AI mistakes could result in an award for attorney fees, says Tamara Barago at Hollingsworth.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here